Genetic Technologies responds to criticism over patent enforcement decision

Genetic Technologies acquires Frozen Puppies Dot Com

GTG to enforce rights to BRCA patents

New head for Melbourne's Genetic Technologies as founder steps back.

Melbourne's Genetic Technologies (ASX:GTX, Nasdaq:GENE) has formed a strategic alliance with MetaMorphix, a developer of new genetic markers.

Genetic Technologies (ASX:GTG; Nasdaq:GENE) has appointed London-based lawyer SJ Berwin to help the company expand its licensing program for its non-coding patents in the UK and in Europe

Mervyn Jacobson, executive chairman of biotech firm Genetic Technologies (ASX:GTG, Nasdaq:GENE), says his company is poised to launch an extensive international search for license partners for its far-reaching non-coding DNA patents.

A major court victory against US firm Applera will put Genetic Technologies (ASX:GTG) in a leadership position in Australian biotechnology, the firm's CEO has predicted.

An elated Dr Mervyn Jacobson, CEO of Genetic Technologies (ASX:GTG, NASDAQ:GENE), flew back to Melbourne from San Francisco this morning after slaying his company's most reluctant dragon, giant US rival Applera.

Two deadlines have come and gone, and a third expires today for Melbourne gene-testing company Genetic Technologies (ASX:GTG; NASDAQ:GENE) and US firm Applera, who were due to announce a resolution of their licensing dispute in California today.

Melbourne gene-testing company Genetic Technologies (ASX:GTG), currently engaged in a protracted court case with giant US rival Applera over licensing and royalties for GTG's controversial non-coding DNA patents, has a potential rival in its own backyard.